Development and validation of a prediction model for lower extremity deep vein thrombosis risk in elderly patients with intracerebral hemorrhage - Scorecard - MDSpire

Development and validation of a prediction model for lower extremity deep vein thrombosis risk in elderly patients with intracerebral hemorrhage

  • By

  • Yi Yang

  • XinYi Guo

  • Ke Luo

  • Wenjuan Zhao

  • Hongru Li

  • Yongli Zhang

  • July 15, 2026

Share

Clinical Scorecard: Creation and assessment of a predictive model for the risk of lower extremity deep vein thrombosis in older adults with intracerebral hemorrhage

At a Glance

CategoryDetail
ConditionLower extremity deep vein thrombosis in elderly patients with intracerebral hemorrhage
Key MechanismsIncreased venous thromboembolism risk due to hemostatic changes following intracerebral hemorrhage.
Target PopulationElderly patients aged over 60 with intracerebral hemorrhage
Care SettingHospitalized patients in a clinical setting

Key Highlights

  • Developed a predictive model for lower extremity deep vein thrombosis risk.
  • Identified four independent predictors: logDFR, eGFR, GCS, and infection.
  • Model demonstrated good discrimination with an AUC of 0.819.
  • Moderate overestimation of risk was noted in calibration assessment.
  • Model applicable across diverse clinical settings as per decision curve analysis.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of cerebral hemorrhage confirmed through CT scan within 48 hours of admission.

Management

  • Initiate IPC on the day of admission; no prophylactic anticoagulant administered.

Monitoring & Follow-up

  • Monitor for development of lower limb deep vein thrombosis during hospitalization.

Risks

  • Elderly patients face a delicate balance between bleeding and thromboembolism risks.

Patient & Prescribing Data

Elderly patients with primary cerebral parenchymal hemorrhage.

Anticoagulation therapy initiated post-diagnosis of LDVT in some cases.

Clinical Best Practices

  • Utilize the developed prediction model for early identification of high-risk patients.
  • Consider individual patient factors when managing antithrombotic therapy.

Related Resources & Content

Original Source(s)

Related Content